| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.1M | +142.9% | +147.9% |
| Cost of Revenue | $1.1M | -32.1% | -18.8% |
| Gross Profit | $962K | +8.7% | -12.8% |
| R&D Expense | $298 | -80.2% | +645.0% |
| SG&A Expense | $829K | +9.9% | -9.3% |
| Operating Income | $133K | +2.8% | -30.0% |
| Pre-tax Income | $192K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $2.3M | +1.1% | +14.4% |
| Current Assets | $3.3M | -1.0% | -9.5% |
| Total Assets | $5.6M | -3.1% | +4.2% |
| Current Liabilities | $2.7M | -9.5% | -15.1% |
| Long-term Debt | $60K | -25.3% | -62.0% |
| Total Liabilities | $3.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $62K | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $286K | — | — |
| +24.8% |
| +10.2% |
| Net Income | $192K | +24.8% | +10.2% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| -10.3% |
| -2.9% |
| Stockholders' Equity | $1.9M | +14.6% | +21.6% |